We are live on ! Find out more
SGRY icon

Surgery Partners

137 hedge funds and large institutions have $2.66B invested in Surgery Partners in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 60 increasing their positions, 33 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

82% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 33

11% more call options, than puts

Call options by funds: $5.07M | Put options by funds: $4.57M

1.26% more ownership

Funds ownership: 101.49%102.75% (+1.3%)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

8% less funds holding

Funds holding: 149137 (-12)

27% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 33

46% less capital invested

Capital invested by funds: $4.96B → $2.66B (-$2.31B)

Holders
137
Holders Change
-12
Holders Change %
-8.05%
% of All Funds
2.31%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
24
Increased
60
Reduced
33
Closed
33
Calls
$5.07M
Puts
$4.57M
Net Calls
+$507K
Net Calls Change
-$12.2M
Name Holding Trade Value Shares
Change
Change in
Stake
RhumbLine Advisers
51
RhumbLine Advisers
Massachusetts
$1.38M +$520K +11,901 +33%
TC
52
TwinBeech Capital
New York
$1.31M +$1.58M +36,233 +399%
AllianceBernstein
53
AllianceBernstein
Tennessee
$1.29M +$271K +6,200 +16%
TP
54
Tranquility Partners
Tennessee
$1.26M
BMSSC
55
B. Metzler seel. Sohn & Co
Germany
$1.21M +$536K +12,264 +42%
RJA
56
Raymond James & Associates
Florida
$1.11M +$34.8K +797 +2%
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$1.1M -$6.99K -160 -0.4%
BNP Paribas Financial Markets
58
BNP Paribas Financial Markets
France
$1.06M +$376K +8,614 +31%
Principal Financial Group
59
Principal Financial Group
Iowa
$1.06M -$1.14M -26,197 -42%
WMSA
60
Weiss Multi-Strategy Advisers
New York
$1.04M +$1.57M +35,906 New
CS
61
Credit Suisse
Switzerland
$988K +$229K +5,248 +18%
CCIA
62
Campbell & Co Investment Adviser
Maryland
$926K +$1.13M +25,903 +424%
Legal & General Group
63
Legal & General Group
United Kingdom
$890K +$46K +1,052 +4%
WB
64
WesBanco Bank
West Virginia
$856K
New York State Common Retirement Fund
65
New York State Common Retirement Fund
New York
$828K +$146K +3,334 +13%
ACM
66
AlphaCrest Capital Management
New York
$741K +$520K +11,913 +87%
SSA
67
Schonfeld Strategic Advisors
New York
$740K -$2.12M -48,584 -65%
Deutsche Bank
68
Deutsche Bank
Germany
$628K -$1.01M -23,009 -51%
SEI Investments
69
SEI Investments
Pennsylvania
$619K -$11K -251 -1%
MIM
70
MetLife Investment Management
New Jersey
$599K +$112K +2,566 +14%
WLPWM
71
Walled Lake Planning & Wealth Management
Illinois
$597K
LFAS
72
Level Four Advisory Services
Texas
$584K +$882K +20,194 New
PL
73
Polianta Ltd
Jersey
$546K +$826K +18,900 New
AIG
74
American International Group
New York
$537K +$66.7K +1,526 +9%
ZIM
75
Zacks Investment Management
Illinois
$490K -$66.1K -1,513 -8%

SGRY Hedge Fund Activity: Q2 2022 in Review

137 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q2 2022, worth a combined $2.66B — down 46% from $4.96B a quarter earlier.

Sellers outnumbered buyers: 33 funds closed out of SGRY and 24 opened new positions — a net loss of 9 holders — while 33 trimmed existing stakes and 60 added.

The largest buyer was Fidelity Investments, adding an estimated $70.2M. The largest seller was Federated Hermes, cutting an estimated $23.4M.

  • 137 institutional investors held Surgery Partners (SGRY) as of Q2 2022, down from 149 in Q1 2022.
  • Funds reported $2.66B of Surgery Partners stock for Q2 2022, down 46% quarter-over-quarter.
  • 24 funds opened new Surgery Partners positions in Q2 2022 and 33 closed out, a net change of -9 holders.
  • The largest Surgery Partners buyer in Q2 2022 was Fidelity Investments, an estimated $70.2M added.
  • The largest Surgery Partners seller in Q2 2022 was Federated Hermes, an estimated $23.4M sold.

Based on aggregated 13F filings for Q2 2022.